基于花菁骨架的PSMA双模态示踪剂:药代动力学调控与染料-蛋白相互作用
本研究合成五种以Cy5染料为功能骨架的99mTc标记PSMA靶向杂合示踪剂,评估其光物理性质、血浆蛋白结合、PSMA亲和力及小鼠体内SPECT与荧光成像。染料组成影响亮度、血清结合、IC50及体内分布,其中99mTc-EuK-(SO3)Cy5-mas3亲和力最高(IC50 19.2±5.8 nM)、肿瘤/肌肉比最大(5157.50±949.17),为最有前景的候选。
要点
- 染料嵌入药效团可调控PSMA示踪剂的光物理与药代动力学性质。
- 99mTc-EuK-(SO3)Cy5-mas3的PSMA亲和力最高,IC50为19.2±5.8 nM。
- 该候选示踪剂肿瘤/肌肉比达5157.50±949.17,支持双模态成像。
核心结论
- 荧光团可内在整合于PSMA靶向小分子示踪剂的药效团中。
- 在EuK邻近的吲哚环上带一个磺酸基的99mTc-EuK-(SO3)Cy5-mas3是最有前景的PSMA显像候选示踪剂。
研究设计与样本
- 合成五种以Cy5染料为功能骨架的PSMA靶向杂合示踪剂:EuK-Cy5-mas3、EuK-(SO3)Cy5-mas3、EuK-Cy5(SO3)-mas3、EuK-(Ar)Cy5-mas3和EuK-Cy5(Ar)-mas3。
- 评估化合物的光物理与化学性质及PSMA亲和力,经99mTc标记后在荷PC346C原位移植瘤的BALB/c裸鼠中进行SPECT显像、生物分布和荧光成像。
主要发现
- 染料组成影响亮度(范围0.3-1.5×10^4 M^-1×cm^-1)、血浆蛋白结合(血清结合范围85.0%±2.3%-90.7%±1.3%;血清稳定性范围76%±0%-89%±6%)、PSMA亲和力(IC50范围19.2±5.8-175.3±61.1 nM)及体内特征。
- 肿瘤/前列腺比范围0.02±0.00-154.73±28.48,肿瘤/肌肉比范围0.46±0.28-5157.50±949.17,并观察到肾、脾和唾液腺滞留。
- 所有示踪剂类似物均可用SPECT和荧光成像识别肿瘤,其中99mTc-EuK-(SO3)Cy5-mas3的IC50为19.2±5.8 nM、肿瘤/肌肉比为5157.50±949.17,性质最有前景。
关键数值与推荐
- PSMA亲和力以IC50表示,范围19.2±5.8-175.3±61.1 nM。
- 血清蛋白结合范围85.0%±2.3%-90.7%±1.3%,血清稳定性范围76%±0%-89%±6%。
- 亮度范围0.3-1.5×10^4 M^-1×cm^-1。
- 肿瘤/前列腺比范围0.02±0.00-154.73±28.48,肿瘤/肌肉比范围0.46±0.28-5157.50±949.17。
临床怎么用
- 99mTc-EuK-(SO3)Cy5-mas3兼具高PSMA亲和力与高肿瘤/肌肉比,可作为SPECT与荧光双模态成像的候选示踪剂。
- 染料骨架的磺酸基位置可影响PSMA亲和力与体内分布,提示可据此优化示踪剂设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Prostate cancer surgery is currently being revolutionized by the use of prostate-specific membrane antigen (PSMA)-targeted radiotracers, for example, 99mTc-labeled PSMA tracer analogs for radioguided surgery. The purpose of this study was to develop a second-generation 99mTc-labeled PSMA-targeted tracer incorporating a fluorescent dye. Methods: Several PSMA-targeted hybrid tracers were synthesized: glutamic acid-urea-lysine (EuK)-Cy5-mas3, EuK-(SO3)Cy5-mas3, EuK-Cy5(SO3)-mas3, EuK-(Ar)Cy5-mas3, and EuK-Cy5(Ar)-mas3; the Cy5 dye acts as a functional backbone between the EuK targeting vector and the 2-mercaptoacetyl-seryl-seryl-seryl (mas3) chelate to study the dye's interaction with PSMA's amphipathic entrance funnel. The compounds were evaluated for their photophysical and chemical properties and PSMA affinity. After radiolabeling with 99mTc, we performed in vivo SPECT imaging, biodistribution, and fluorescence imaging on BALB/c nude mice with orthotopically transplanted PC346C tumors. Results: The dye composition influenced the photophysical properties (brightness range 0.3-1.5 × 104 M-1 × cm-1), plasma protein interactions (range 85.0% ± 2.3%-90.7% ± 1.3% bound to serum, range 76% ± 0%-89% ± 6% stability in serum), PSMA affinity (half-maximal inhibitory concentration [IC50] range 19.2 ± 5.8-175.3 ± 61.1 nM) and in vivo characteristics (tumor-to-prostate and tumor-to-muscle ratios range 0.02 ± 0.00-154.73 ± 28.48 and 0.46 ± 0.28-5,157.50 ± 949.17, respectively; renal, splenic, and salivary retention). Even though all tracer analogs allowed tumor identification with SPECT and fluorescence imaging, 99mTc-EuK-(SO3)Cy5-mas3 had the most promising properties (e.g., half-maximal inhibitory concentration, 19.2 ± 5.8, tumor-to-muscle ratio, 5,157.50 ± 949.17). Conclusion: Our findings demonstrate the intrinsic integration of a fluorophore in the pharmacophore in PSMA-targeted small-molecule tracers. In this design, having 1 sulfonate on the indole moiety adjacent to EuK (99mTc-EuK-(SO3)Cy5-mas3) yielded the most promising tracer candidate for imaging of PSMA.
引用
- Hensbergen AW, Buckle T, van Willigen DM, et al. Hybrid Tracers Based on Cyanine Backbones Targeting Prostate-Specific Membrane Antigen: Tuning Pharmacokinetic Properties and Exploring Dye-Protein Interaction. J Nucl Med. 2019. PMID: 31481575. doi:10.2967/jnumed.119.233064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。